Flow and Services divisions achieved growth and margin improvement, while Chemtech stabilized its core business amid project delays. Sales rose 1.0% and EBITDA margin improved to 15.5%, but free cash flow was impacted by higher net working capital. Full-year guidance is confirmed.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.